ArticleScience China. Life sciences2025

Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy.

Linghui Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.